Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1996-05-22
1997-05-13
Conrad, Joseph
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 7, 514119, 514507, 514563, 530331, A61K 3800, A61K 3816, A61K 3166, A61K 31215
Patent
active
056292856
ABSTRACT:
Compounds and methods are disclosed that are useful in inhibiting the TNF-.alpha. converting enzyme (TACE) responsible for cleavage of TNF-.alpha. precursor to provide biologically active TNF-.alpha.. The compounds employed in the invention are peptidyl derivatives having active groups capable of inhibiting TACE such as, hydroxamates, thiols, phosphoryls and carboxyls.
REFERENCES:
patent: 4382081 (1983-05-01), Sundeen et al.
patent: 4599361 (1986-07-01), Dickens et al.
patent: 4681894 (1987-07-01), Murray et al.
patent: 4943587 (1990-07-01), Cetenko et al.
patent: 5093356 (1992-03-01), Girard et al.
patent: 5110831 (1992-05-01), Magolda et al.
patent: 5114953 (1992-05-01), Galardy et al.
patent: 5145858 (1992-09-01), Adams et al.
patent: 5304549 (1994-04-01), Broadhurst et al.
patent: 5304604 (1994-04-01), Davidson et al.
Spatola, et al., CA Selects: Amino Acids, Peptides & Proteins, Issue 17:13 (1993).
Davies, et al., Cancer Research, Issue 53, 2087-2091 (1993).
Nixon, et al., Int. Journ. Tiss. Reac., XIII(5): 237-243 (1991).
Scuderi, P., J. of Immunology, 143, No. 1, 168-173 (1989).
Kriegler et al., Cell, 53: 45-53 (1988).
Spatola, et al., Tetrahedron, vol. 44, No. 3, 821-833 (1988).
Hudson, et al., Int. J. Peptide Protein Research, 14: 177-185 (1985).
Spatola et al., Vega Data, vol. 1, Issue 3, 267 (1983).
Hann, M., The Royal Society of Chemistry, 307-314 (1982).
Morely, J.S., TIPS, 463-468 (1980).
Gearing et al., Nature, 370:555 (1994).
McGeehan, et al., Nature, 370: 558 (1994).
Schultz, et al., Invest. Ophtham. & Visual Sci. vol. 33, No. 12, 3325 (1992).
Andrews, et al., Agents Actions 37: 147 (1992).
Black, et al., Nature, 370: 218 (1994).
Han, et al., J. Exp. Med., 172: 391 (1990).
Sampaio, et al., J. Exp. Med., 173: 699 (1991).
Black Roy A.
Fitzner Jeffrey N.
Sleath Paul R.
Conrad Joseph
Immunex Corporation
Malaska Stephen L.
LandOfFree
Inhibitors of TNF-.alpha. secretion does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibitors of TNF-.alpha. secretion, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of TNF-.alpha. secretion will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1385365